Coronavirus: Vaccination

(asked on 16th November 2020) - View Source

Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps he has taken to ensure that any covid-19 vaccines are sold at cost and are accessible to (a) low-income and (b) middle-income countries.


Answered by
Amanda Solloway Portrait
Amanda Solloway
Government Whip, Lord Commissioner of HM Treasury
This question was answered on 24th November 2020

The UK’s bilateral deals with pharmaceutical companies for covid-19 vaccines include funding for research and development, investment in manufacturing and vaccine trials. This investment supports the global scale up of vaccine production and therefore the quantity of vaccines available for low and middle-income countries. The UK is a strong supporter of the multilateral Covid-19 Global Vaccine Access Facility (COVAX) initiative as a means to both get vaccines for the UK population and ensure equitable global access. The UK announced that it will contribute up to £500 million for the COVAX Advanced Market Commitment, which will give lower and middle-income countries equitable access to vaccines that are developed.

Reticulating Splines